Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share Attributable to Common Stock - Antidilutive Securities (Details)

v3.22.2.2
Net Loss per Share Attributable to Common Stock - Antidilutive Securities (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share        
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 147,707 43,996 147,707 43,966
Non-vested restricted stock awards        
Antidilutive Securities Excluded from Computation of Earnings Per Share        
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 1,186,136 529,997 1,186,136 529,997
Common stock warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share        
Common stock equivalents excluded from computation of diluted net loss per share attributable to common stock for the periods presented because their effect would have been anti-dilutive 240,100 240,100 240,100 240,100